Kate Gartlan

Kate Gartlan

QIMR Berghofer Medical Research Institute - Herston / Australia
Others
AD Scientific Index ID: 4461737
person_outline Kate Gartlan's MOST POPULAR ARTICLES
1-) Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trialGA Kennedy, A Varelias, S Vuckovic, L Le Texier, KH Gartlan, P Zhang, ...The Lancet Oncology 15 (13), 1451-1459, 20142102014
2-) Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigensF Wegmann, KH Gartlan, AM Harandi, SA Brinckmann, M Coccia, ...Nature biotechnology 30 (9), 883-888, 20121922012
3-) Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockadeSA Minnie, RD Kuns, KH Gartlan, P Zhang, AN Wilkinson, L Samson, ...Blood, The Journal of the American Society of Hematology 132 (16), 1675-1688, 20181432018
4-) Eomesodermin promotes the development of type 1 regulatory T (TR1) cellsP Zhang, JS Lee, KH Gartlan, IS Schuster, I Comerford, A Varelias, ...Science immunology 2 (10), eaah7152, 20171522017
5-) Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effectsKH Gartlan, KA Markey, A Varelias, MD Bunting, M Koyama, RD Kuns, ...Blood, The Journal of the American Society of Hematology 126 (13), 1609-1620, 20151262015